News and press releases
HERMES PHARMA announces €25 million investment to bolster capacity
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
HERMES PHARMA Again Achieves Silver CSR Award from EcoVadis
EcoVadis is one of the leading and most trusted provider of business sustainability ratings. The silver medal acknowledges HERMES PHARMA's continued commitment to sustainable and responsible practices and was awarded on the back of a rigorous review of the company’s business operations.
HERMES PHARMA Publishes its 2023 Product & Development Portfolio
Interested in HERMES PHARMA's newly developed products? The new 2023 Product & Development Portfolio is now ready for download.
FDA Approves Magnesium Claim for Heart Health, HERMES PHARMA Expands Magnesium Portfolio
Our new ‘on the go’ heart health supplement combines the power of magnesium and selected B vitamins (also implicated in cardiovascular health) with the convenience of an ultra-user-friendly dosage form.
HERMES PHARMA Publishes its 2022 Product & Development Portfolio
Interested in HERMES PHARMA's newly developed products? The new 2022 Product & Development Portfolio is now ready for download.
HERMES PHARMA Announces Spin-out from HERMES Arzneimittel
The forward-looking change marks a new phase for HERMES PHARMA bringing greater independence while retaining long-term stability for its third party customers.
HERMES PHARMA Adds Another Top Sustainability Award
EcoVadis has awarded a second silver CSR medal to HERMES PHARMA in recognition of its sustainability commitment.
Swallowing - a Physical and Mechanical Hazard
People of all ages can experience pill swallowing difficulties. An informative presentation from toxicologist Dr Michael J. Kerins (Procter & Gamble) discusses these difficulties, highlighting how improved taste and alternate product forms among other considerations can help to alleviate these challenges.
HERMES PHARMA Joins DCAT
DCAT is a not-for-profit business development organization facilitating knowledge-sharing and relationships among its global corporate members in the pharmaceutical industry.
HERMES PHARMA Achieves Top Rating for Sustainability Performance from EcoVadis
Recognition for the company’s commitment and continuous efforts to meet international CSR standards
HERMES PHARMA Opens New Era of Delivering Food Supplements at Vitafoods Europe 2019
The expert in user-friendly dosage forms launches HERMES NutriCaps, a novel and innovative way to deliver food supplements
Johannes Burges Family Foundation
Family Foundation Ensures Future Independence of HERMES PHARMA and Other Companies of the Johannes Burges Group
User-friendly Medicines
Professor Clive Wilson, Strathclyde Institute of Pharmacy & Biomedical Sciences, Glasgow and HERMES PHARMA’s Dr. Martin Koeberle wrote a chapter on user-friendly medicines which has been recently published in the book "Pharmaceutical Formulation – The Science & Technology of Dosage Forms" ( by the Royal Society of Chemistry)
HERMES PHARMA Obtains Prestigious GMP Certification from Russian Authorities
The successful inspection allows HERMES PHARMA to manufacture for the Russian market
HERMES PHARMA Improves Opening of Tablet Tubes Used for Lozenges, Effervescent and Chewable Tablets
New Patented Desiccant Stopper Makes Products Even More User-Friendly
HERMES PHARMA Awarded European Organic Certificate
Wolfratshausen GMP Facility Meets Organic Food Trend Requirements
HERMES PHARMA Makes Hot Melt Coating Available for the Pharma Industry
Commercial Production in GMP Environment Started to Mask the Sour and Metallic Taste of Acetylcysteine
Carinthia Innovation and Research Award Conferred to HERMES PHARMA
HERMES PHARMA earned the first prize for its research in innovative oral dosage forms
User-Friendly Dosage Form Expert, HERMES PHARMA, Brings Easy-to-Swallow Medicines to US Market
HERMES PHARMA has today announced plans to ramp up its expansion into the US market
Conventional Tablets May No Longer Be the Go-To-Solution
Market study reveals difficulties swallowing tablets wide-spread and opens up new revenue opportunities
HERMES PHARMA Completes Successful Routine FDA Inspection of Production Facility
Inspection Opens Door for HERMES PHARMA to Increase Production of User-friendly Solid Oral Dosage Forms for the US
Swallowing Tablets is a Massive Problem for Growing Numbers of People
User-Friendly Dosage Forms Enable Pharmaceutical Companies to Innovate
New Taste-Masking Technologies Facilitate User-Friendly Pharmaceuticals
Odor and taste are key for the acceptance of dosage forms that dissolve in the mouth. Hermes Pharma, INNOJET Herbert Hüttlin, RCPE and Karl Franzens University research new approaches to increase patient compliance and improve production processes.
Oxford Pharmascience and HERMES PHARMA partner to develop new Ibuprofen product
Heads of Terms signed for a range of OXP zero ibuprofen products
HERMES PHARMA joins the Consumer Healthcare Products Association (CHPA)
HERMES PHARMA is committed to making medicines more user-friendly in the US
Print
